Publications by authors named "Wesley Partridge"

Claim this Profile
S
Safety and Tolerability of GalNAc-Conjugated Antisense Drugs Compared to the Same-Sequence 2'--Methoxyethyl-Modified Antisense Drugs: Results from an Integrated Assessment of Phase 1 Clinical Trial Data.
Brenda F Baker, Shuting Xia, Wesley Partridge, Jeffery A Engelhardt, Sotirios Tsimikas

Nucleic Acid Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlations between preclinical BJAB assay ranking of antisense drugs and clinical trial adverse events.
Wesley Partridge, Sebastien A Burel, Annie Ferng, Shuting Xia, T Jesse Kwoh

Clin Transl Sci· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Assessment of Phase 2 Data on GalNAc-Conjugated 2'--Methoxyethyl-Modified Antisense Oligonucleotides.
Brenda F Baker, Shuting Xia, Wesley Partridge, T Jesse Kwoh, Sotirios Tsimikas

Nucleic Acid Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in the Tolerability Profile of 2'--Methoxyethyl Chimeric Antisense Oligonucleotides in Parallel with Advances in Design, Screening, and Other Methods.
Wesley Partridge, Shuting Xia, T Jesse Kwoh, Sanjay Bhanot, Richard S Geary

Nucleic Acid Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis